CXCR4 and neoplasm: Hypothesising that the expression of CXCR4 and/or HER2, their respective pathways and their interaction are involved in mediating tumor progression and metastatic homing, each therapeutic group was evaluated separately as to the intensity of HER2- and CXCR4-expression levels.